ECM Weekly (1 September 2018) - Meituan, NIO, Aavas, Hua Medicine, Qutoutiao
Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...
429 Views
Meituan Dianping (美团点评) IPO: Thoughts on Valuation - The Market Structure and the Variables (Part 3)
Meituan Dianping is said to launch its book building on September 3rd next week. We covered the company's fundamentals in our previous two...
981 Views
Meituan-Dianping IPO, Part 3: Sum-Of-Parts Approach Suggests US$50 Bn Valuation Quite Unrealistic
Recent media reports (see articles here and here) suggest Meituan Dianping (MEITUAN CH) will attempt to complete its listing in Hong Kong by...
932 Views
Meituan Dianping IPO Preview: Unpalatable Valuation Due to Structural Limitations
Meituan Dianping (MEITUAN CH) is set to kick off its IPO roadshow on 3 September and will be listed on the Hong Kong Exchange on 20 September....
685 Views
Meituan Dianping IPO: Although Profitable in 2023, It Is Still Worth Purchasing the Stock
Our primary valuation of Meituan Dianping (Meituan) is US$ 156 bn. In this valuation, payable to merchant DCF reaches up to 162%, operating loss is...
579 Views